Cargando…

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy

BACKGROUND: The use of intraprostatic gold fiducial markers (FMs) ensures highly accurate and precise image-guided radiation therapy for patients diagnosed with prostate cancer thanks to the ease of localising FMs on photon-based imaging, like Computed Tomography (CT) images. Recently, Magnetic Reso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maspero, Matteo, Seevinck, Peter R., Willems, Nicole J. W., Sikkes, Gonda G., de Kogel, Geja J., de Boer, Hans C. J., van der Voort van Zyp, Jochem R. N., van den Berg, Cornelis A. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989467/ https://www.ncbi.nlm.nih.gov/pubmed/29871656 http://dx.doi.org/10.1186/s13014-018-1029-7

Ejemplares similares

Clinical implementation of MRI-based organs-at-risk auto-segmentation with convolutional networks for prostate radiotherapy
por: Savenije, Mark H. F., et al.
Publicado: (2020)

Patient preferences for treatment modalities for localised prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

Feasibility of magnetic resonance imaging-only rectum radiotherapy with a commercial synthetic computed tomography generation solution
por: Maspero, Matteo, et al.
Publicado: (2018)

Nanofabrication of a gold fiducial array on specimen support for electron tomography
por: Koning, Roman I., et al.
Publicado: (2013)

Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study
por: Willigenburg, Thomas, et al.
Publicado: (2020)

Fast and accurate deformable contour propagation for intra-fraction adaptive magnetic resonance-guided prostate radiotherapy
por: Willigenburg, Thomas, et al.
Publicado: (2022)

Health-related quality of life after ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: reporting the patient’s perspective
por: van Son, Marieke, et al.
Publicado: (2020)

Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator
por: Willigenburg, Thomas, et al.
Publicado: (2021)

Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers
por: Goudschaal, Karin, et al.
Publicado: (2021)

Deep learning for automated contouring of neurovascular structures on magnetic resonance imaging for prostate cancer patients
por: van den Berg, Ingeborg, et al.
Publicado: (2023)

On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy
por: de Muinck Keizer, Daan M., et al.
Publicado: (2021)

Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives
por: van Son, Marieke, et al.
Publicado: (2018)

Analytical Models for Pose Estimate Variance of Planar Fiducial Markers for Mobile Robot Localisation
por: Adámek, Roman, et al.
Publicado: (2023)

Fast contour propagation for MR‐guided prostate radiotherapy using convolutional neural networks
por: Eppenhof, K.A.J., et al.
Publicado: (2020)

Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients
por: van Son, Marieke, et al.
Publicado: (2020)

Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients
por: Teunissen, Frederik R., et al.
Publicado: (2021)

MRI‐based synthetic CT shows equivalence to conventional CT for the morphological assessment of the hip joint
por: Florkow, Mateusz C., et al.
Publicado: (2021)

Perineal recurrence of prostate cancer six years after trans-perineal brachytherapy
por: Eppinga, Wietse, et al.
Publicado: (2014)

Fluorescently Labelled Silica Coated Gold Nanoparticles as Fiducial Markers for Correlative Light and Electron Microscopy
por: Fokkema, Jantina, et al.
Publicado: (2018)

Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Willigenburg, Thomas, et al.
Publicado: (2021)

EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types
por: Rigter, Lisanne S., et al.
Publicado: (2019)

Determination of optimal fiducial marker across image‐guided radiation therapy (IGRT) modalities: visibility and artifact analysis of gold, carbon, and polymer fiducial markers
por: Handsfield, Lydia L., et al.
Publicado: (2012)

Problems and Promises of Introducing the Magnetic Resonance Imaging Linear Accelerator Into Routine Care: The Case of Prostate Cancer
por: Hehakaya, Charisma, et al.
Publicado: (2020)

Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system
por: Kontaxis, Charis, et al.
Publicado: (2020)

Using C‐Arm X‐ray images from marker insertion to confirm the gold fiducial marker identification in an MRI‐only prostate radiotherapy workflow
por: Gustafsson, Christian, et al.
Publicado: (2018)

Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy
por: Peters, Max, et al.
Publicado: (2016)

Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer
por: Van Son, Marieke J, et al.
Publicado: (2018)

Fiducial Measurements on Coll
por: Baubillier, M, et al.
Publicado: (1972)

Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer
por: Teunissen, Frederik R., et al.
Publicado: (2022)

EUS-guided fiducial gold marker placement in metastatic colon cancer to the spleen
por: Deshmukh, Ameya, et al.
Publicado: (2021)

A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy
por: Lim Joon, Daryl, et al.
Publicado: (2023)

Realizing the value of complex medical technology: Demonstrating cost-effectiveness is not enough
por: Hehakaya, C., et al.
Publicado: (2023)

Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator
por: den Hartogh, Mariska D., et al.
Publicado: (2019)

BioXmark® liquid fiducials to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial
por: Opbroek, Thirza J.S., et al.
Publicado: (2022)

Dose reduction potential of using gold fiducial markers for kilovoltage image‐guided radiotherapy
por: Takei, Yoshiki, et al.
Publicado: (2020)

Online adaptive MR-guided radiotherapy: Conformity of contour adaptation for prostate cancer, rectal cancer and lymph node oligometastases among radiation therapists and radiation oncologists
por: Rasing, Marnix J.A., et al.
Publicado: (2022)

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

The Development and External Validation of Artificial Intelligence-Driven MRI-Based Models to Improve Prediction of Lesion-Specific Extraprostatic Extension in Patients with Prostate Cancer
por: van den Berg, Ingeborg, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c4fs7pibm3hvl63ku6v745pdhg